BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38438051)

  • 21. Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities.
    Subaiea GM; Syed RU; Afsar S; Alhaidan TMS; Alzammay SA; Alrashidi AA; Alrowaili SF; Alshelaly DA; Alenezi AMSRA
    Pathol Res Pract; 2024 Jan; 253():155022. PubMed ID: 38086292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-coding RNA's prevalence as biomarkers for prognostic, diagnostic, and clinical utility in breast cancer.
    Ali R; Laskar SA; Khan NJ; Wahab S; Khalid M
    Funct Integr Genomics; 2023 Jun; 23(2):195. PubMed ID: 37270446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation of noncoding RNAs: new insights into osteogenesis and common bone diseases.
    Yu L; Xia K; Cen X; Huang X; Sun W; Zhao Z; Liu J
    Stem Cell Res Ther; 2020 Mar; 11(1):109. PubMed ID: 32143708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy.
    Varela MA; Roberts TC; Wood MJ
    Neurotherapeutics; 2013 Oct; 10(4):621-31. PubMed ID: 24068583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
    Sankrityayan H; Kulkarni YA; Gaikwad AB
    Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An epigenetic modulator with promising therapeutic impacts against gastrointestinal cancers: A mechanistic review on microRNA-195.
    Davoodvandi A; Rafiyan M; Asemi Z; Matini SA
    Pathol Res Pract; 2023 Aug; 248():154680. PubMed ID: 37467635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-coding RNA dysregulation in skin cancers.
    Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
    Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of non-coding RNAs in the epigenetic regulation of pediatric cancers.
    Pathania AS; Prathipati P; Pandey MK; Byrareddy SN; Coulter DW; Gupta SC; Challagundla KB
    Semin Cancer Biol; 2022 Aug; 83():227-241. PubMed ID: 33910063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of noncoding RNAs and untranslated regions in cancer: A review.
    Zhang Y; Yang M; Yang S; Hong F
    Medicine (Baltimore); 2022 Aug; 101(33):e30045. PubMed ID: 35984196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive review of web-based non-coding RNA resources for cancer research.
    Zheng Y; Liu L; Shukla GC
    Cancer Lett; 2017 Oct; 407():1-8. PubMed ID: 28823961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy.
    Dong Y; Xu S; Liu J; Ponnusamy M; Zhao Y; Zhang Y; Wang Q; Li P; Wang K
    Int J Biol Sci; 2018; 14(9):1133-1141. PubMed ID: 29989099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ncRNADrug: a database for validated and predicted ncRNAs associated with drug resistance and targeted by drugs.
    Cao X; Zhou X; Hou F; Huang YE; Yuan M; Long M; Chen S; Lei W; Zhu J; Chen J; Zhang T; Guo AY; Jiang W
    Nucleic Acids Res; 2024 Jan; 52(D1):D1393-D1399. PubMed ID: 37953323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular profile of non-coding RNA-mediated glycolysis control in human cancers.
    Mirzaei S; Ranjbar B; Tackallou SH
    Pathol Res Pract; 2023 Aug; 248():154708. PubMed ID: 37536019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short and Long Noncoding RNAs Regulate the Epigenetic Status of Cells.
    Uchida S; Bolli R
    Antioxid Redox Signal; 2018 Sep; 29(9):832-845. PubMed ID: 28847161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles.
    Razavi ZS; Tajiknia V; Majidi S; Ghandali M; Mirzaei HR; Rahimian N; Hamblin MR; Mirzaei H
    Crit Rev Oncol Hematol; 2021 Jan; 157():103192. PubMed ID: 33290823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.
    Yu XH; Wang HF; Wu JB; Wang SS; Tang YJ; Tang YL; Liang XH
    Life Sci; 2019 Aug; 231():116509. PubMed ID: 31152812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA (Epi)genetics in cardiovascular diseases.
    Elia L; Condorelli G
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):11-6. PubMed ID: 26205296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.